Skip to main content
. Author manuscript; available in PMC: 2019 Jan 8.
Published in final edited form as: Expert Opin Investig Drugs. 2017 Jul 20;26(8):897–907. doi: 10.1080/13543784.2017.1353601

Table 1. Overview of commonly used antiarrhythmic drugs (AADs) and their electrophysiological targets.

Only targets with a half-maximal inhibitory concentration (IC50) of a similar order of magnitude as that of the primary target are listed [12].

Class AAD Primary target Other targets Comments
IA Quinidine INa (intermediate kinetics) IKr, Ito
IB Lidocaine INa (fast kinetics)
IB Mexiletine INa (fast kinetics)
IB Ranolazine INa IKr, RyR2, ICa,L Preferentially inhibiting INaL
IC Flecainide INa (slow kinetics) IKr, RyR2
IC Propafenone INa (slow kinetics) IKr, RyR2, βAR
II Metoprolol β1AR
II Nebivolol β1AR RyR2, NOS
II Carvedilol βAR RyR2, αAR
III Amiodarone IKr IK,ACh, IK2P, ICa,L, INa, βAR, αAR, M2R Exhibits effects of all four classes
III Dronedarone IKr IK,ACh, IK2P, ICa,L, INa, βAR, αAR Exhibits effects of all four classes
III Dofetilide IKr
III Sotalol IKr βAR
III Vernakalant IKr INa, IKur, IK2P
IV Verapamil ICa,L IKr
V Ivabradine If
V Digitalis INaK